Skip to main content

Table 1 Demographic data of the study population (N = 46)

From: Neutralizing antibody and T cell responses against SARS-CoV-2 variants of concern following ChAdOx-1 or BNT162b2 boosting in the elderly previously immunized with CoronaVac vaccine

Demographic data

ChAdOx-1 (N = 24)

BNT162b2 (N = 22)

p value

Age (years)

70.1 ± 8.3

(min-max, 64–92)

74.6 ± 9.4

(min-max, 60–97)

0.093

BMI (kg/m2)

23.9 ± 2.8

23.3 ± 4.3

0.547

Sex (male)

16 (66.7)

10 (45.5)

0.234

Smoking status

  

1.000

 Nonsmoker

22 (91.7)

20 (90.9)

 

 Ex-smoker

2 (8.3)

2 (9.1)

 

Underlying diseases

  

0.505

 Cardiovascular

11 (45.8)

13 (59.1)

 

 Respiratory

4 (16.7)

0 (0.0)

 

 Metabolic

1 (4.2)

2 (9.1)

 

 Neuromuscular

1 (4.2)

2 (9.1)

 

 Cardiovascular and respiratory

1 (4.2)

1 (4.5)

 

 Cardiovascular and metabolic

2 (8.3)

1 (4.5)

 

 Respiratory and metabolic

1 (4.2)

0 (0.0)

 

 Respiratory and gastrointestinal

1 (4.2)

0 (0.0)

 

 None

2 (8.3)

3 (13.6)

 
  1. Data are presented as the mean ± SD or N (%)